BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8889804)

  • 21. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers.
    Huard J; Feero WG; Watkins SC; Hoffman EP; Rosenblatt DJ; Glorioso JC
    J Virol; 1996 Nov; 70(11):8117-23. PubMed ID: 8892937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR; Heath AW; Jennings R
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
    Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
    J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.
    Shieh MT; WuDunn D; Montgomery RI; Esko JD; Spear PG
    J Cell Biol; 1992 Mar; 116(5):1273-81. PubMed ID: 1310996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods].
    Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O
    Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction.
    Hu YP; Lin SY; Huang CY; Zulueta MM; Liu JY; Chang W; Hung SC
    Nat Chem; 2011 Jun; 3(7):557-63. PubMed ID: 21697878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Real time observation of binding of measles virus to Vero cells and neutralization of measles virus by human immunoglobulin using optical biosensor--a new real time diagnosis system for viral infections].
    Inoue K; Arai T
    Kansenshogaku Zasshi; 1998 Mar; 72(3):273-8. PubMed ID: 9585701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus: receptors and ligands for cell entry.
    Spear PG
    Cell Microbiol; 2004 May; 6(5):401-10. PubMed ID: 15056211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
    Yoon M; Zago A; Shukla D; Spear PG
    J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
    Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H
    J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate.
    Pertel PE; Fridberg A; Parish ML; Spear PG
    Virology; 2001 Jan; 279(1):313-24. PubMed ID: 11145912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Microvesicles in the Spread of Herpes Simplex Virus 1 in Oligodendrocytic Cells.
    Bello-Morales R; Praena B; de la Nuez C; Rejas MT; Guerra M; Galán-Ganga M; Izquierdo M; Calvo V; Krummenacher C; López-Guerrero JA
    J Virol; 2018 May; 92(10):. PubMed ID: 29514899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans.
    Peerboom N; Block S; Altgärde N; Wahlsten O; Möller S; Schnabelrauch M; Trybala E; Bergström T; Bally M
    Biophys J; 2017 Sep; 113(6):1223-1234. PubMed ID: 28697896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV-1 virions engineered for specific binding to cell surface receptors.
    Grandi P; Wang S; Schuback D; Krasnykh V; Spear M; Curiel DT; Manservigi R; Breakefield XO
    Mol Ther; 2004 Mar; 9(3):419-27. PubMed ID: 15006609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection.
    Yakoub AM; Rawal N; Maus E; Baldwin J; Shukla D; Tiwari V
    J Virol; 2014 Nov; 88(21):12915-22. PubMed ID: 25142596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection.
    Sharthiya H; Seng C; Van Kuppevelt TH; Tiwari V; Fornaro M
    J Neurovirol; 2017 Jun; 23(3):483-491. PubMed ID: 28326469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel method to assay herpes simplex virus neutralizing antibodies using BHKICP6LacZ-5 (ELVIS) cells.
    Ashley RL; Dalessio J; Sekulovich RE
    Viral Immunol; 1997; 10(4):213-20. PubMed ID: 9473152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody.
    Mannini-Palenzona A; Moschella A; Costanzo F; Manservigi R; Monini P
    New Microbiol; 1995 Oct; 18(4):351-8. PubMed ID: 8590387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.